FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Public Meeting on Device User Fees

04/18/2007

Federal Register Notice: FDA is holding a public meeting to discuss its proposed recommendations for the reauthorization of the Me...

FDA, National Cancer Institute Sign MOU

04/18/2007

Federal Register Notice: FDA is providing notice of a memorandum of understanding between FDA and the National Cancer Institute to...

Comments Extended on Changes to Approved Applications

04/13/2007

Federal Register Notice: FDA is reopening until 5/18, the comment period for the 2/7 public meeting that sought input on issues th...

Anti-Infective Drugs Panel Meeting Canceled

04/12/2007

Federal Register Notice: FDA’s Anti-Infective Drugs Advisory Committee scheduled for 4/11, is canceled. For more information...

FDA OKs Altana Canine Ointment

04/11/2007

Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of an Altana, Inc. ANADA that provide...

Guidance on Drug, Biologic Dosage and Administration

04/09/2007

Federal Register Notice: FDA is making available a draft guidance for industry entitled Dosage and Administration Section of Label...

Guidance on Submitting AERS to IRBs

04/09/2007

Federal Register Notice: FDA is a making a draft guidance available for industry, Guidance for Clinical Investigators, Sponsors, a...

Orally Disintegrating Tablets Guidance

04/09/2007

Federal Register Notice: FDA is making available a draft guidance for industry, Orally Disintegrating Tablets. It provides manufac...

Tigan Suppositories Withdrawn

04/09/2007

Federal Register Notice: FDA withdraws approval of an NDA for Tigan (trimethobenzamide hydrochloride) suppositories due to lack of...

Blood Products Panel to Meet

04/09/2007

Federal Register Notice: FDA’s Blood Products Advisory Committee will meet 4/26, from 2 p.m. to 6 p.m. and 4/27, from 8 a.m....